PXN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.069600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.267200E-01
Normal-vs-Stage2
3.005400E-01
Normal-vs-Stage3
7.791600E-01
Normal-vs-Stage4
7.410100E-02
Stage1-vs-Stage2
6.840600E-01
Stage1-vs-Stage3
2.133000E-01
Stage1-vs-Stage4
8.419000E-01
Stage2-vs-Stage3
1.365400E-01
Stage2-vs-Stage4
1.387210E-01
Stage3-vs-Stage4
3.189600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.986400E-01
Normal-vs-AfricanAmerican
5.139400E-01
Normal-vs-Asian
6.342400E-01
Caucasian-vs-AfricanAmerican
6.093600E-01
Caucasian-vs-Asian
2.861000E-01
AfricanAmerican-vs-Asian
8.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.496000E-01
Normal-vs-Female
4.006200E-01
Male-vs-Female
1.094220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.769600E-01
Normal-vs-Age(41-60Yrs)
9.784200E-02
Normal-vs-Age(61-80Yrs)
4.645000E-01
Normal-vs-Age(81-100Yrs)
7.667500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.989400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.293600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.674600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.162700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.765800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.758800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.874000E-01
Normal-vs-Daily Drinker
1.873630E-01
Normal-vs-Weekly Drinker
4.286600E-01
Normal-vs-Occasional Drinker
7.990500E-02
Normal-vs-Social Drinker
3.549400E-01
Non Drinker-vs-Daily Drinker
1.472610E-01
Non Drinker-vs-Weekly Drinker
9.063200E-01
Non Drinker-vs-Occasional Drinker
2.160100E-02
Non Drinker-vs-Social Drinker
7.629200E-01
Daily Drinker-vs-Weekly Drinker
2.670800E-01
Daily Drinker-vs-Occasional Drinker
3.702600E-01
Daily Drinker-vs-Social Drinker
3.231400E-01
Weekly Drinker-vs-Occasional Drinker
6.166100E-02
Weekly Drinker-vs-Social Drinker
8.709200E-01
Occasional Drinker-vs-Social Drinker
7.366000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.774400E-01
Normal-vs-Grade 2
7.425800E-02
Normal-vs-Grade 3
1.025200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.550760E-01
Grade 1-vs-Grade 3
3.154300E-02
Grade 1-vs-Grade 4
2.774400E-01
Grade 2-vs-Grade 3
1.234570E-01
Grade 2-vs-Grade 4
7.425800E-02
Grade 3-vs-Grade 4
1.025200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.709000E-01
Normal-vs-NonDiabetic
2.369000E-01
Diabetic-vs-NonDiabetic
1.243770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.300400E-02
Normal-vs-NoPancreatitis
3.127800E-01
Pancreatitis-vs-NoPancreatitis
4.467000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.070600E-01
Normal-vs-N1
3.186800E-01
N0-vs-N1
5.891400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.65470000000179E-05
Normal-vs-TP53-NonMutant
3.606000E-02
TP53-Mutant-vs-TP53-NonMutant
6.382200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
